Related Experiment Video
Updated: Jun 2, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced
Mingjiong Zhang1, Jiahua Cui2, Haoyan Chen1
1Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Immune functions decline with aging, leading to increased susceptibility to various diseases including tumors. Exploring aging-related molecular targets in elderly patients with cancer is thus highly sought after. Here we find that an ER transmembrane enzyme, sterol O-acyltransferase 2 (SOAT2), is overexpressed in regulatory T (Treg) cells from elderly patients with lung squamous cell carcinoma (LSCC), while radiomics analysis of LSCC patients associates increased SOAT2 expression with reduced immune infiltration and poor prognosis. Mechanically, ex vivo human and mouse Treg cell data and in vivo mouse tumor models suggest that SOAT2 overexpression in Treg cells promotes cholesterol metabolism by activating the SREBP2-HMGCR-GGPP pathway, leading to enhanced Treg suppresser functions but reduced CD8+ T cell proliferation, migration, homeostasis and anti-tumor immunity. Our study thus identifies a potential mechanism responsible for altered Treg function in the context of immune aging, and also implicates SOAT2 as a potential target for tumor immunotherapy.
Insights
Sterol O-acyltransferase 2 (SOAT2) is overexpressed in aging regulatory T (Treg) cells, impairing anti-tumor immunity in lung cancer. Targeting SOAT2 may improve immunotherapy for elderly cancer patients.
Area of Science:
- Immunology
- Oncology
- Aging Research
Background:
- Immune functions decline with aging, increasing cancer susceptibility.
- Identifying aging-related molecular targets in elderly cancer patients is crucial.
- Regulatory T (Treg) cells play a key role in immune regulation and cancer progression.
Purpose of the Study:
- To investigate the role of sterol O-acyltransferase 2 (SOAT2) in aging-related immune dysfunction in lung squamous cell carcinoma (LSCC).
- To explore SOAT2 as a potential therapeutic target for enhancing anti-tumor immunity in elderly cancer patients.
Main Methods:
- Analysis of SOAT2 expression in Treg cells from elderly LSCC patients.
- Radiomics analysis of LSCC patient data.
- Ex vivo human and mouse Treg cell experiments.
- In vivo mouse tumor models.
- Investigation of the SREBP2-HMGCR-GGPP pathway.
Main Results:
- SOAT2 is overexpressed in Treg cells of elderly LSCC patients.
- Increased SOAT2 expression correlates with reduced immune infiltration and poor prognosis in LSCC.
- SOAT2 overexpression in Treg cells enhances cholesterol metabolism via the SREBP2-HMGCR-GGPP pathway.
- SOAT2 promotes Treg suppressive functions while inhibiting CD8+ T cell proliferation, migration, and anti-tumor immunity.
Conclusions:
- SOAT2 overexpression in Treg cells contributes to immune aging and impaired anti-tumor immunity.
- SOAT2 represents a potential therapeutic target for improving immunotherapy outcomes in elderly cancer patients.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Replicative Cell Senescence